A detailed history of Squarepoint Ops LLC transactions in Biomea Fusion, Inc. stock. As of the latest transaction made, Squarepoint Ops LLC holds 22,793 shares of BMEA stock, worth $29,175. This represents 0.0% of its overall portfolio holdings.

Number of Shares
22,793
Previous 23,214 1.81%
Holding current value
$29,175
Previous $41,000 12.2%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 14, 2025

SELL
$1.53 - $2.1 $644 - $884
-421 Reduced 1.81%
22,793 $46,000
Q2 2025

Aug 14, 2025

BUY
$1.37 - $2.9 $31,803 - $67,320
23,214 New
23,214 $41,000
Q4 2024

Feb 14, 2025

BUY
$3.88 - $12.41 $270,040 - $863,711
69,598 New
69,598 $270,000
Q2 2024

Aug 14, 2024

BUY
$4.14 - $15.3 $217,879 - $805,208
52,628 New
52,628 $236,000
Q4 2023

Feb 14, 2024

BUY
$8.37 - $19.8 $923,855 - $2.19 Million
110,377 New
110,377 $1.6 Million

Others Institutions Holding BMEA

About Biomea Fusion, Inc.


  • Ticker BMEA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 29,290,600
  • Market Cap $37.5M
  • Description
  • Biomea Fusion, Inc., a biopharmaceutical company, focuses on the discovery and development of covalent small molecule drugs to treat patients with genetically defined cancers and metabolic diseases. Its lead product candidate is BMF-219, an orally bioavailable, potent, and selective covalent inhibitor of menin, a transcriptional regulator in onc...
More about BMEA
Track This Portfolio

Track Squarepoint Ops LLC Portfolio

Follow Squarepoint Ops LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

News

Stay updated on Squarepoint Ops LLC with notifications on news.